Zofran Birth Defect Claims
Cleveland Birth Defect Lawyers at Spangenberg Shibley & Liber LLP
Spangenberg lawyers have been investigating the link between Zofran taken for morning sickness during the first trimester of pregnancy and serious fetal injuries involving cleft lip, cleft palate, and congenital heart defects. As a result of our extensive investigation, we believe there is now strong evidence that Zofran (ondansetron) may be the cause of these defects.
The FDA never approved this drug for morning sickness and GlaxoSmithKline (GSK), the maker of this drug, paid a $2 billion settlement in a civil lawsuit that involved allegations that GSK illegally promoted its Zofran drug to be prescribed to expectant mothers. This settlement did not include payments for injuries suffered due to the use of Zofran. You and your child may be legally entitled to compensation for pain and suffering, medical costs, loss of income, emotional distress and other damages.
If you took Zofran while pregnant and your child has health defects, contact our attorneys as soon as possible. You may be eligible to hold GlaxoSmithKline accountable for their negligence and secure financial support for your family. Call (216) 600-0114 today for a free legal consultation, and we can investigate the circumstances of your child’s birth defect and whether Zofran was the cause.
Zofran Use Linked to Heart Defects in Infants
Swedish researchers published a study of 1,400 Zofran-exposed pregnancies (from 1998-2012) in the December 2014 edition of Reproductive Toxicology. It showed a two-fold increase in the risk of "hole in the heart" defects.
Zofran has been linked to the following heart defects:
- Atrial Septal Defect (hole in the heart)
- Ventricular Septal Defect
- Heart Murmurs